Besides, IL-17 could be capable of inducing RANKL, the main stimulatory factor for the differentiation and activation of osteoclasts in bone inflammatory diseases like rheumatoid arthritis and PD [34, 35]. Here, TNFSF11 is linked to bone inflammation disease.